Psychedelic Developer Bright Minds Biosciences Lists on NASDAQ with Hopes to Battle Dravet Syndrome | High Times
Psychedelic Developer Bright Minds Biosciences Lists on NASDAQ with Hopes to Battle Dravet Syndrome | High Times Total 0 Share
Psychedelic Developer Bright Minds Biosciences Lists on NASDAQ with Hopes to Battle Dravet Syndrome | High Times Total 0 Share
Following up on encouraging news in August from Willow Biosciences about its large production runs of biosynthetic cannabigerol (CBG), another biotechnology company has announced the first sale….
CARLSBAD, Calif. – Greenwich Biosciences, Inc. and its parent company GW Pharmaceuticals, a British company involved in the development and manufacturing of plant-derived cannabinoid therapy, announced Monday that its prescription….
Boldly going where no cannabis has gone before, Front Range Biosciences and SpaceCells USA Inc. announced plans to send cannabis to the International Space Station, aboard the SpaceX CRS-20 cargo flight scheduled….
Boldly going where no cannabis has gone before, Front Range Biosciences and SpaceCells USA Inc. announced plans to send cannabis to the International Space Station, aboard the SpaceX CRS-20 cargo flight scheduled….